2021 WHA Resolution on Strengthening Local Production to Improve Access
Analysis of precedential value
This Resolution was passed at the Seventy-fourth World Health Assembly (WHA). The WHA is the decision-making body of the World Health Organization. It includes delegations from every UN member state, which gather annually to address questions about WHO’s governance, budget, and progress. Although WHA resolutions are centred on health, they engage various related topics ranging from military aggression to migrant rights.
Used as precedent
access to health products
“Urges Member States, where appropriate, based on the national context: to apply a holistic approach in strengthening local production by considering, for example, promoting research and development, transparency of markets for medicines and other health technologies, regulatory systems strengthening, access to sustainable and affordable financing, development of skilled human resources, access to technology transfer on voluntary and mutually agreed terms for production and needs-based innovation, the aggregation of national and regional demand, and appropriate incentives for private-sector investment, particularly in the context of achieving universal health coverage.” (paragraph 1(5))
“Urges Member States, where appropriate, based on the national context: to engage in global, regional and subregional networks related to promoting sustainable local production of quality, safe, effective and affordable medicines, and to further enhance multistakeholder collaboration.” (paragraph 1(6))
“Urges Member States, where appropriate, based on the national context: to further engage in North–South and South–South development cooperation, partnerships and networks to build and improve the transfer of technology related to health innovation on voluntary and mutually agreed terms and in line with their international obligations.” (paragraph 1(7))
“Urges Member States, where appropriate, based on the national context: to take into account the rights and obligations in the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement), including those affirmed by the Doha Declaration on the TRIPS Agreement and Public Health, in order to promote access to medicines and other health technologies for all.” (paragraph 1(8))